Narcan (naloxone) is best known as an emergency overdose reversal drug, but it has several other medical uses. Its core action, blocking opioid receptors, turns out to be useful in situations ranging from addiction treatment to severe constipation to itching caused by liver disease. Some of these uses are well established, while others remain investigational.
How Narcan Works Beyond Overdose
Naloxone blocks opioid receptors throughout the body. In an overdose, that means it displaces the drug causing respiratory failure and restores normal breathing within minutes. But opioid receptors aren’t just involved in pain and breathing. They play roles in gut motility, itch signaling, blood pressure regulation, and even how the brain processes reward and pleasure. Blocking those receptors in different contexts produces very different therapeutic effects.
Deterring Misuse in Addiction Medications
One of the most widespread non-overdose uses of naloxone is as an ingredient in Suboxone, the combination tablet and film used to treat opioid use disorder. Suboxone pairs buprenorphine (which manages cravings and withdrawal) with naloxone. When taken as directed, dissolved under the tongue, the naloxone is poorly absorbed and has little effect. But if someone crushes the tablet and injects it, the naloxone becomes fully active and triggers immediate withdrawal symptoms: nausea, sweating, agitation, and intense discomfort.
This design is intentional. The naloxone serves as a built-in misuse deterrent. It doesn’t contribute to the treatment itself when the medication is used correctly. It’s there specifically to make injection unappealing for people who might otherwise divert the drug.
Treating Opioid-Induced Constipation
Chronic opioid use slows the gut to a crawl. Opioid receptors line the gastrointestinal tract, and when activated, they reduce the muscle contractions that move food and waste through the intestines. This is one of the most common and persistent side effects of long-term opioid therapy, and standard laxatives often don’t resolve it.
When naloxone is given by mouth rather than injected, something useful happens. It undergoes heavy metabolism in the liver before reaching the bloodstream, leaving only about 2% of the dose circulating systemically. That means it can block opioid receptors in the gut wall without reversing pain relief in the brain. In one study of ICU patients, 15 out of 16 had a bowel movement after oral naloxone, with a median time of about 24 hours. No patients experienced withdrawal or loss of pain control.
This approach takes advantage of naloxone’s poor oral bioavailability, a property that’s normally considered a limitation. For constipation, it becomes the entire point.
Relieving Severe Itch From Liver Disease
People with cholestatic liver disease, where bile flow is blocked or impaired, often develop intense, relentless itching that doesn’t respond to antihistamines or topical treatments. Research has linked this itching to elevated levels of the body’s own opioid-like compounds. The theory is that bile buildup triggers excess endorphin activity, which activates itch pathways through opioid receptors in the skin and nervous system.
Intravenous naloxone and its oral cousin naltrexone have both shown effectiveness for this type of itch in multiple studies and a meta-analysis, according to the American Association for the Study of Liver Diseases. There’s one notable caution: because these drugs block opioid receptors, they can trigger a brief withdrawal-like reaction even in people who have never taken opioid drugs. The body’s own endorphin system gets disrupted. For that reason, treatment typically starts at a low dose and increases gradually.
Experimental Use in Septic Shock
The injectable form of naloxone has actually carried FDA labeling noting it “may be useful as an adjunctive agent to increase blood pressure in the management of septic shock.” During severe infection, the body releases large amounts of endorphins, which can contribute to the dangerous drop in blood pressure that defines septic shock. Blocking those receptors with naloxone has, in some cases, produced a rise in blood pressure lasting several hours.
However, this use never became standard practice. The blood pressure improvement hasn’t been shown to improve survival, and the treatment carries real risks: agitation, pulmonary edema, dangerous heart rhythms, and seizures have all been reported. Optimal dosing was never established. This remains a largely historical footnote, an example of a biologically plausible idea that didn’t pan out clinically.
Research Into Binge Eating
Because opioid receptors help govern how the brain experiences pleasure from food, researchers have tested whether blocking those receptors changes eating behavior. In one study, intravenous naloxone reduced both the enjoyment of and the consumption of sweet, high-fat foods in women diagnosed with binge eating disorder. The effect was specific to binge eaters. Women without binge eating patterns didn’t change their food intake.
This line of research hasn’t produced an approved naloxone-based treatment for eating disorders, but it illustrates how broadly the opioid system influences behavior. Naltrexone, a longer-acting oral relative of naloxone, is already part of an approved weight management medication that works on similar principles.
Congenital Insensitivity to Pain
In one of the more fascinating research applications, naloxone was tested in a patient born unable to feel pain, a rare genetic condition. The patient’s pain reflex threshold was 350% higher than normal. After receiving naloxone, that threshold dropped rapidly, approaching normal levels within two to three minutes. The body’s own opioid system appeared to be in overdrive, suppressing pain signals that most people feel automatically.
Remarkably, even though the reflex measurements nearly normalized, the patient still didn’t report feeling pain. Researchers speculated this might reflect a missing emotional component, the learned response to painful stimuli that develops through a lifetime of experience. This remains a research curiosity rather than a treatment, but it reshaped scientific understanding of how the body’s natural opioid system can malfunction.
Why One Drug Has So Many Potential Uses
The common thread across all of these applications is the same receptor. Opioid receptors exist in the brain, spinal cord, gut, skin, and blood vessels. They regulate pain, breathing, mood, digestion, itch, and blood pressure. A drug that blocks those receptors will have different effects depending on how it’s delivered (injected vs. swallowed), where it acts (gut vs. brain), and what condition is driving the symptoms.
Narcan’s FDA-approved indication remains narrow: emergency treatment of known or suspected opioid overdose. But the pharmacology of naloxone extends well beyond that single use, and clinicians have leveraged it in creative ways for decades. The overdose reversal role is what made it famous, but the molecule itself is far more versatile than most people realize.